MMS(MMS)
MMS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $5.30B | $5.55B |
| Low | $5.28B | $5.50B |
| High | $5.33B | $5.60B |
| EBITDA Avg | $734M | $770M |
| Low | $732M | $763M |
| High | $738M | $777M |
| EBIT Avg | $593M | $622M |
| Low | $591M | $616M |
| High | $596M | $627M |
| Net Income Avg | $489M | $522M |
| Low | $487M | $500M |
| High | $491M | $545M |
| EPS Avg | $8.44 | $9.07 |
| Low | $8.40 | $8.63 |
| High | $8.48 | $9.41 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 |
|---|---|---|---|---|---|
| Revenue Avg | $1.32B | $1.41B | $1.38B | $1.42B | $1.39B |
| Low | $1.31B | $1.41B | $1.38B | $1.41B | $1.39B |
| High | $1.33B | $1.42B | $1.39B | $1.42B | $1.40B |
| EBITDA Avg | $183M | $195M | $191M | $196M | $193M |
| Low | $182M | $195M | $191M | $196M | $193M |
| High | $184M | $197M | $192M | $197M | $194M |
| EBIT Avg | $148M | $158M | $155M | $158M | $156M |
| Low | $147M | $157M | $154M | $158M | $156M |
| High | $149M | $159M | $155M | $159M | $157M |
| Net Income Avg | $127M | $127M | $123M | $129M | $126M |
| Low | $126M | $127M | $123M | $128M | $126M |
| High | $128M | $128M | $124M | $130M | $127M |
| EPS Avg | $2.31 | $2.31 | $2.24 | $2.34 | $2.30 |
| Low | $2.28 | $2.30 | $2.23 | $2.33 | $2.29 |
| High | $2.34 | $2.33 | $2.26 | $2.36 | $2.32 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |